| 1.9 |
7.6 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.2 |
3.6 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.1 |
4.2 |
GO:0010897 |
negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.9 |
1.9 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.9 |
2.8 |
GO:0050894 |
determination of affect(GO:0050894) |
| 0.8 |
3.4 |
GO:0061349 |
chemoattraction of serotonergic neuron axon(GO:0036517) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
| 0.8 |
3.2 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.7 |
3.0 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.7 |
4.3 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.7 |
2.1 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.7 |
5.4 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.7 |
5.3 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.7 |
0.7 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.7 |
2.6 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.7 |
0.7 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.6 |
3.2 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.6 |
3.1 |
GO:0061015 |
snRNA import into nucleus(GO:0061015) |
| 0.6 |
0.6 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.6 |
1.8 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.6 |
3.4 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.6 |
1.7 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.6 |
3.9 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.6 |
1.7 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.6 |
2.2 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.5 |
3.8 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.5 |
2.2 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.5 |
1.6 |
GO:0002728 |
negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.5 |
1.1 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.5 |
0.5 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.5 |
1.0 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.5 |
1.0 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.5 |
3.0 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.5 |
2.5 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.5 |
2.9 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.5 |
1.4 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.5 |
2.3 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.5 |
1.4 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.5 |
2.3 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.5 |
1.4 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.5 |
1.4 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.4 |
1.3 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.4 |
1.3 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.4 |
2.2 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.4 |
1.3 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.4 |
1.3 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.4 |
1.3 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.4 |
2.1 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 0.4 |
7.5 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.4 |
2.1 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.4 |
1.6 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.4 |
2.9 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.4 |
2.4 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.4 |
2.8 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.4 |
1.2 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.4 |
1.6 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.4 |
1.9 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.4 |
0.4 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.4 |
1.5 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.4 |
1.5 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.4 |
2.3 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.4 |
1.9 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.4 |
0.4 |
GO:1904738 |
vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
| 0.4 |
1.1 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.4 |
1.1 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.4 |
3.3 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.4 |
1.1 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.4 |
7.6 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.4 |
1.4 |
GO:0015883 |
FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.4 |
1.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.4 |
1.4 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.4 |
2.1 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.3 |
1.0 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.3 |
2.4 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.3 |
0.3 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 |
0.3 |
GO:0044771 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
| 0.3 |
1.0 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.3 |
1.0 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.3 |
2.0 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.3 |
1.3 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.3 |
1.6 |
GO:2000691 |
regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.3 |
0.3 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 |
1.0 |
GO:2000502 |
negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.3 |
1.6 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.3 |
1.0 |
GO:0070512 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.3 |
2.5 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.3 |
5.7 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.3 |
5.6 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.3 |
0.6 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.3 |
1.8 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 |
0.3 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.3 |
0.9 |
GO:2000625 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.3 |
1.5 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.3 |
5.7 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.3 |
0.9 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.3 |
0.3 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.3 |
0.9 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.3 |
0.3 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.3 |
0.3 |
GO:0010332 |
response to gamma radiation(GO:0010332) |
| 0.3 |
0.3 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.3 |
1.1 |
GO:0072255 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.3 |
0.3 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.3 |
1.1 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.3 |
1.4 |
GO:1901545 |
cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.3 |
0.6 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.3 |
1.1 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.3 |
3.0 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.3 |
2.2 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.3 |
4.1 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.3 |
0.8 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.3 |
1.9 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.3 |
3.0 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.3 |
5.1 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
1.3 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.3 |
1.3 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.3 |
1.3 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.3 |
1.6 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.3 |
1.0 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.3 |
1.0 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.3 |
0.8 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.3 |
1.5 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.3 |
1.0 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.3 |
1.3 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.3 |
1.8 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.3 |
0.3 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.2 |
2.2 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.2 |
1.0 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.2 |
1.5 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 |
1.0 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.2 |
1.0 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.2 |
1.2 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.2 |
0.7 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.2 |
1.4 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.2 |
0.9 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.2 |
1.9 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.2 |
0.2 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.2 |
0.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 |
2.5 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.2 |
0.2 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.2 |
1.1 |
GO:1904882 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.2 |
1.1 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.2 |
0.7 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
0.7 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.2 |
1.1 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.2 |
0.7 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.2 |
1.3 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.2 |
0.4 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 |
0.7 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.2 |
2.2 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 |
1.1 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.2 |
2.2 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.2 |
1.1 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.2 |
1.1 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.2 |
0.2 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.2 |
0.4 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.2 |
0.8 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 |
2.1 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.2 |
1.0 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.2 |
0.8 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.2 |
0.8 |
GO:0044053 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.2 |
0.2 |
GO:1901655 |
cellular response to ketone(GO:1901655) |
| 0.2 |
0.6 |
GO:0016237 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
| 0.2 |
0.6 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.2 |
2.0 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.2 |
0.2 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.2 |
1.4 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.2 |
0.2 |
GO:0032309 |
icosanoid secretion(GO:0032309) acid secretion(GO:0046717) |
| 0.2 |
1.6 |
GO:0046959 |
habituation(GO:0046959) |
| 0.2 |
0.6 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.2 |
0.6 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.2 |
0.6 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.2 |
1.8 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.2 |
0.4 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.2 |
1.2 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 |
0.6 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.2 |
1.6 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.2 |
2.4 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.2 |
0.2 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 0.2 |
1.2 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 |
0.6 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.2 |
0.2 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.2 |
0.6 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.2 |
3.3 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.2 |
1.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.2 |
0.6 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
3.5 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 |
1.3 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.2 |
0.6 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.2 |
0.6 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.2 |
4.7 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.2 |
0.6 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.2 |
1.9 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.2 |
1.1 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 |
1.7 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.2 |
1.5 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
1.3 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.2 |
2.6 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.2 |
0.7 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.2 |
0.5 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.2 |
1.6 |
GO:0046618 |
drug export(GO:0046618) |
| 0.2 |
0.7 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
0.7 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 |
1.1 |
GO:0048704 |
embryonic skeletal system morphogenesis(GO:0048704) |
| 0.2 |
0.9 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.2 |
5.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.2 |
0.7 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.2 |
2.1 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 |
1.6 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 |
0.4 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.2 |
1.6 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.2 |
0.7 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.2 |
2.4 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.2 |
2.1 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.2 |
1.2 |
GO:0070383 |
DNA cytosine deamination(GO:0070383) |
| 0.2 |
27.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.2 |
0.3 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
0.5 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 |
0.7 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.2 |
0.5 |
GO:0071353 |
response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
| 0.2 |
1.4 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.2 |
0.7 |
GO:0046502 |
uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.2 |
0.9 |
GO:0097384 |
cellular lipid biosynthetic process(GO:0097384) |
| 0.2 |
0.8 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.2 |
0.3 |
GO:0002877 |
acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.2 |
0.7 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.2 |
1.2 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.2 |
0.3 |
GO:0048241 |
epinephrine transport(GO:0048241) |
| 0.2 |
0.5 |
GO:0072716 |
response to actinomycin D(GO:0072716) |
| 0.2 |
3.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.2 |
2.3 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
1.8 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.2 |
0.8 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.2 |
0.8 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.2 |
0.8 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.2 |
1.1 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.2 |
0.6 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.2 |
0.5 |
GO:2000619 |
negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.2 |
0.5 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.2 |
0.5 |
GO:0051664 |
spindle pole body duplication(GO:0030474) nuclear pore distribution(GO:0031081) spindle pole body organization(GO:0051300) nuclear pore localization(GO:0051664) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.2 |
0.3 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.2 |
1.1 |
GO:2000782 |
regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.2 |
0.8 |
GO:0033590 |
response to cobalamin(GO:0033590) |
| 0.2 |
1.4 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
1.4 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.2 |
0.6 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.2 |
0.2 |
GO:0046102 |
inosine metabolic process(GO:0046102) |
| 0.2 |
0.6 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
0.5 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 |
0.6 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
1.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.2 |
0.2 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.2 |
1.5 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
9.4 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.2 |
0.2 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 |
0.5 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
0.8 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 |
0.3 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.2 |
1.7 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
1.2 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
0.4 |
GO:0030239 |
myofibril assembly(GO:0030239) |
| 0.1 |
0.3 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 |
0.4 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.1 |
0.4 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.1 |
1.0 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.4 |
GO:0006424 |
glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.1 |
0.7 |
GO:0035936 |
testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.1 |
0.7 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 0.1 |
0.4 |
GO:0018969 |
thiocyanate metabolic process(GO:0018969) |
| 0.1 |
0.4 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.1 |
0.6 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 |
0.7 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.1 |
0.7 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 |
0.1 |
GO:0001656 |
metanephros development(GO:0001656) |
| 0.1 |
0.4 |
GO:0043137 |
DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 |
0.6 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.1 |
0.3 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.6 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
2.2 |
GO:0075713 |
establishment of integrated proviral latency(GO:0075713) |
| 0.1 |
0.1 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.1 |
7.3 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.7 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 |
0.6 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 |
1.0 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
0.7 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
1.3 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.1 |
0.6 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.1 |
0.4 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.1 |
1.1 |
GO:0045007 |
depurination(GO:0045007) |
| 0.1 |
0.4 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 |
0.4 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.1 |
1.0 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
1.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.1 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 |
2.2 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.1 |
3.2 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
1.8 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
1.0 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.1 |
1.4 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
1.0 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.1 |
0.4 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.5 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.1 |
1.1 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
2.5 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
0.4 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.1 |
0.1 |
GO:1901216 |
positive regulation of neuron death(GO:1901216) |
| 0.1 |
0.3 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.1 |
0.8 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.3 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.1 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 |
0.8 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.1 |
0.5 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.4 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 |
0.3 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.5 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.5 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 |
1.0 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 |
0.1 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.4 |
GO:0071262 |
regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.1 |
0.4 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 |
0.5 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.1 |
0.5 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.3 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.1 |
0.1 |
GO:0051495 |
positive regulation of cytoskeleton organization(GO:0051495) |
| 0.1 |
0.6 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 |
1.0 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
1.3 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.1 |
0.6 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
0.5 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.1 |
0.5 |
GO:0022406 |
membrane docking(GO:0022406) |
| 0.1 |
0.5 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.1 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 |
0.5 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 |
1.9 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.6 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.4 |
GO:0090290 |
positive regulation of osteoclast proliferation(GO:0090290) |
| 0.1 |
0.4 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.1 |
1.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
2.1 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
1.5 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
2.6 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.1 |
0.2 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
0.6 |
GO:1902957 |
negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.1 |
0.5 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.1 |
0.6 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.1 |
0.2 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.1 |
1.4 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.1 |
0.8 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 |
0.2 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 |
3.3 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
9.8 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.1 |
0.2 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 |
0.6 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 |
0.2 |
GO:0051534 |
regulation of NFAT protein import into nucleus(GO:0051532) negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.1 |
GO:0019081 |
viral translation(GO:0019081) |
| 0.1 |
0.8 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.1 |
GO:0009698 |
phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 0.1 |
1.1 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 |
0.4 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 0.1 |
0.7 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 |
0.2 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
1.7 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.1 |
GO:0002085 |
inhibition of neuroepithelial cell differentiation(GO:0002085) |
| 0.1 |
0.7 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.1 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 |
0.3 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.1 |
0.5 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.1 |
0.6 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 |
1.0 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.1 |
0.3 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.1 |
0.3 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 |
1.9 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.1 |
0.6 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.4 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.1 |
0.3 |
GO:0009080 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.1 |
0.2 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.1 |
0.2 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
0.1 |
GO:0007595 |
lactation(GO:0007595) |
| 0.1 |
0.2 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.1 |
0.4 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 |
0.3 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.1 |
0.1 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
2.0 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 |
0.4 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 |
0.4 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.1 |
0.4 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.1 |
0.3 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 |
1.1 |
GO:0032888 |
regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.1 |
2.0 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 |
3.7 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.1 |
3.6 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 |
0.4 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 0.1 |
0.1 |
GO:2000466 |
negative regulation of glycogen (starch) synthase activity(GO:2000466) |
| 0.1 |
0.1 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 |
0.4 |
GO:0014740 |
negative regulation of muscle hyperplasia(GO:0014740) |
| 0.1 |
0.9 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.7 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.1 |
2.5 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
0.6 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
0.7 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 |
0.3 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.1 |
1.0 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.1 |
1.4 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 0.1 |
0.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
1.3 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
1.5 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.5 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.3 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
0.4 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.1 |
0.2 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.1 |
1.0 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
1.4 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.6 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 |
2.8 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.3 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.1 |
0.4 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.1 |
0.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
0.7 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.1 |
1.7 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 |
0.3 |
GO:0008052 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.1 |
0.4 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.1 |
0.3 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.1 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.1 |
0.1 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
0.6 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.1 |
0.9 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.1 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 |
0.3 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) |
| 0.1 |
0.6 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.4 |
GO:1905216 |
positive regulation of RNA binding(GO:1905216) |
| 0.1 |
1.4 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.1 |
1.0 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.6 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.1 |
0.2 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.1 |
4.0 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.1 |
0.4 |
GO:2000553 |
regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.1 |
0.4 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 |
0.3 |
GO:0006174 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.1 |
0.7 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 |
0.3 |
GO:1904395 |
positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.1 |
0.8 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.3 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.1 |
0.8 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.1 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.1 |
0.9 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.5 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
2.4 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.7 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 |
0.3 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.9 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 |
0.7 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
1.1 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 |
1.2 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.1 |
0.3 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
0.3 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.1 |
1.7 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 |
0.6 |
GO:0051126 |
negative regulation of actin nucleation(GO:0051126) |
| 0.1 |
1.6 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
3.2 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.4 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.1 |
0.5 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.1 |
0.5 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 |
0.4 |
GO:1902661 |
positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.1 |
0.4 |
GO:1990737 |
response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.1 |
1.5 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
2.5 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.2 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.1 |
0.5 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
0.4 |
GO:0045626 |
negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.1 |
1.6 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.1 |
0.1 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) |
| 0.1 |
1.0 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.1 |
0.2 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.1 |
3.1 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.1 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.1 |
3.8 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
0.3 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
0.4 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.1 |
0.5 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
1.1 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
0.3 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.1 |
0.5 |
GO:0048070 |
regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) regulation of developmental pigmentation(GO:0048070) positive regulation of developmental pigmentation(GO:0048087) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.1 |
0.4 |
GO:0097045 |
phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.1 |
1.3 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
2.7 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.1 |
0.2 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.1 |
0.1 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.1 |
0.3 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
2.2 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.3 |
GO:1990654 |
sebum secreting cell proliferation(GO:1990654) |
| 0.1 |
0.2 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
0.3 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
0.3 |
GO:0006173 |
dADP biosynthetic process(GO:0006173) |
| 0.1 |
2.4 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.1 |
0.4 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
3.6 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.1 |
0.5 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.1 |
0.2 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.2 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
0.4 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.1 |
1.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
1.5 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.1 |
0.6 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.1 |
0.3 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
| 0.1 |
0.6 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.3 |
GO:0006147 |
guanine catabolic process(GO:0006147) |
| 0.1 |
0.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.1 |
0.1 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) |
| 0.1 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.7 |
GO:0042559 |
pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.1 |
0.4 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 |
0.5 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.7 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.1 |
0.5 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.4 |
GO:0045338 |
farnesyl diphosphate metabolic process(GO:0045338) |
| 0.1 |
0.5 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 |
0.1 |
GO:0010536 |
positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.1 |
0.6 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 |
1.9 |
GO:1904874 |
positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.1 |
0.4 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.1 |
1.3 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
0.5 |
GO:1903223 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
0.1 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 |
0.6 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 |
0.5 |
GO:0060369 |
positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.1 |
1.7 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 |
0.5 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.1 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.3 |
GO:0009407 |
toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.1 |
0.2 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.1 |
0.2 |
GO:0034059 |
response to anoxia(GO:0034059) |
| 0.1 |
1.1 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
0.8 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 |
0.2 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.1 |
0.2 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
0.2 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 |
0.2 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 |
4.2 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
1.8 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
1.6 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.8 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.1 |
1.6 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 |
2.3 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
1.4 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.1 |
0.3 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 |
0.3 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.1 |
0.2 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.6 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.1 |
0.5 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
0.8 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
0.9 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.3 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
1.8 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.1 |
0.8 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
1.3 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.1 |
0.1 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.1 |
1.6 |
GO:0006293 |
nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.1 |
0.2 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.1 |
0.2 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 |
0.6 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.1 |
0.4 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.2 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 |
0.2 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 |
0.5 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.1 |
0.2 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.1 |
0.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.3 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.1 |
0.8 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.1 |
0.2 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.1 |
0.2 |
GO:0048769 |
sarcomerogenesis(GO:0048769) |
| 0.1 |
1.3 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.1 |
0.8 |
GO:0045046 |
protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
0.4 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.5 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
2.0 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.2 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
2.0 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
1.4 |
GO:0072540 |
T-helper 17 cell lineage commitment(GO:0072540) |
| 0.1 |
0.3 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
0.1 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.1 |
3.5 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
0.1 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 |
0.4 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 |
1.6 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.1 |
GO:0035261 |
external genitalia morphogenesis(GO:0035261) |
| 0.1 |
1.1 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 |
0.3 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.5 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
0.5 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
0.9 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
0.1 |
GO:1903078 |
positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.1 |
0.1 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 |
0.6 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.1 |
0.6 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.1 |
0.6 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.1 |
0.9 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.2 |
GO:1903573 |
negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
| 0.1 |
0.3 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.6 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
0.1 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
| 0.1 |
0.2 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.1 |
1.6 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
0.1 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.1 |
0.1 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
0.2 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.1 |
0.6 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.1 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 |
0.1 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.1 |
0.1 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
0.4 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 |
0.2 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.1 |
0.5 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 |
0.2 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 |
0.5 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 |
2.0 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.1 |
0.4 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.1 |
0.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.8 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
0.4 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
0.4 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 |
0.1 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.7 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.2 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
1.6 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.1 |
0.5 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 |
0.4 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
0.2 |
GO:0034370 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 |
0.4 |
GO:0001781 |
neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.1 |
0.2 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 |
1.3 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.1 |
0.1 |
GO:2000232 |
regulation of rRNA processing(GO:2000232) |
| 0.1 |
0.3 |
GO:0042418 |
epinephrine biosynthetic process(GO:0042418) |
| 0.1 |
1.5 |
GO:0071305 |
cellular response to vitamin D(GO:0071305) |
| 0.1 |
1.1 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.7 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.3 |
GO:1903979 |
regulation of microglial cell activation(GO:1903978) negative regulation of microglial cell activation(GO:1903979) |
| 0.1 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
6.9 |
GO:0051436 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
| 0.1 |
1.8 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 |
1.6 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.1 |
1.3 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.1 |
0.5 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.4 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
4.3 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.1 |
0.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.1 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.5 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 |
0.4 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
0.3 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 |
0.3 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.1 |
0.2 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 |
0.6 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.3 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 |
2.0 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.1 |
0.3 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.1 |
0.3 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.4 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.2 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.1 |
0.2 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 |
1.4 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.4 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 |
0.1 |
GO:1901856 |
negative regulation of cellular respiration(GO:1901856) |
| 0.1 |
0.7 |
GO:0032769 |
negative regulation of monooxygenase activity(GO:0032769) |
| 0.1 |
0.1 |
GO:0051439 |
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.1 |
0.4 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.2 |
GO:0051884 |
regulation of anagen(GO:0051884) |
| 0.1 |
0.8 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.1 |
0.1 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.1 |
2.4 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 |
0.6 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 |
0.7 |
GO:0045040 |
outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
0.1 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.1 |
0.1 |
GO:1902563 |
regulation of neutrophil activation(GO:1902563) |
| 0.1 |
0.1 |
GO:0045005 |
DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.1 |
0.3 |
GO:0050668 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.1 |
0.5 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
0.3 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.4 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
0.4 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.1 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.1 |
0.2 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.1 |
0.4 |
GO:0060026 |
convergent extension(GO:0060026) |
| 0.1 |
0.1 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.1 |
2.1 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 |
0.2 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.1 |
0.7 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) |
| 0.1 |
0.6 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.1 |
0.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.6 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.1 |
0.8 |
GO:0034724 |
DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.5 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 |
0.2 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
1.1 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 |
0.1 |
GO:1902369 |
negative regulation of RNA catabolic process(GO:1902369) |
| 0.1 |
0.2 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.1 |
0.2 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.2 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.1 |
2.3 |
GO:0007007 |
inner mitochondrial membrane organization(GO:0007007) |
| 0.1 |
0.3 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.2 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.1 |
1.3 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.1 |
0.2 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.1 |
0.2 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.1 |
0.1 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.1 |
0.6 |
GO:0071402 |
cellular response to lipoprotein particle stimulus(GO:0071402) |
| 0.1 |
0.1 |
GO:0010877 |
lipid transport involved in lipid storage(GO:0010877) |
| 0.1 |
0.3 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.1 |
0.5 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.1 |
0.9 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.1 |
0.2 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.1 |
0.2 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 |
0.2 |
GO:0071871 |
response to epinephrine(GO:0071871) |
| 0.1 |
1.0 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 |
1.5 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.1 |
0.7 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
0.2 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
2.3 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.1 |
0.7 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 |
0.3 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.7 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
1.3 |
GO:0019184 |
nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.1 |
0.4 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.1 |
0.1 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
| 0.1 |
0.3 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.1 |
0.1 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 |
0.9 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
0.3 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.1 |
0.9 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.1 |
0.6 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
1.9 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.3 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 |
0.6 |
GO:1902176 |
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.1 |
0.5 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.1 |
0.2 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 |
0.1 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.1 |
0.4 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.2 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.1 |
0.4 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
1.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.3 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 |
0.4 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
0.8 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.1 |
GO:0036473 |
cell death in response to oxidative stress(GO:0036473) |
| 0.1 |
0.3 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.1 |
1.0 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.4 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 |
0.2 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.2 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 |
0.5 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 |
0.1 |
GO:0015874 |
norepinephrine transport(GO:0015874) norepinephrine secretion(GO:0048243) |
| 0.1 |
0.1 |
GO:1902725 |
negative regulation of satellite cell differentiation(GO:1902725) |
| 0.1 |
0.2 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
5.6 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.1 |
0.6 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.0 |
0.3 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
0.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.0 |
2.2 |
GO:0046949 |
fatty-acyl-CoA biosynthetic process(GO:0046949) |
| 0.0 |
0.1 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
0.1 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.0 |
1.7 |
GO:0007098 |
centrosome cycle(GO:0007098) |
| 0.0 |
0.5 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.0 |
0.2 |
GO:0032988 |
ribonucleoprotein complex disassembly(GO:0032988) |
| 0.0 |
0.1 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.0 |
0.2 |
GO:0030805 |
regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.0 |
0.3 |
GO:0021592 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.5 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.1 |
GO:0071504 |
response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 0.0 |
0.1 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.0 |
1.6 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.0 |
0.9 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.6 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
0.3 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.0 |
0.3 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 |
0.1 |
GO:0010873 |
positive regulation of cholesterol esterification(GO:0010873) |
| 0.0 |
0.2 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.0 |
2.7 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.2 |
GO:1900005 |
positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.0 |
0.2 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.9 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.2 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.8 |
GO:1901985 |
positive regulation of protein acetylation(GO:1901985) |
| 0.0 |
0.5 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.6 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 |
0.1 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.0 |
0.9 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.6 |
GO:0048505 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.0 |
0.6 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.0 |
0.2 |
GO:0046777 |
protein autophosphorylation(GO:0046777) |
| 0.0 |
0.4 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.0 |
0.9 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.2 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.0 |
1.4 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.4 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 |
0.1 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.0 |
0.1 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.0 |
0.6 |
GO:0017148 |
negative regulation of translation(GO:0017148) |
| 0.0 |
0.1 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) |
| 0.0 |
0.2 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.0 |
0.2 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.0 |
0.2 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.2 |
GO:0042472 |
inner ear morphogenesis(GO:0042472) |
| 0.0 |
0.4 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.0 |
0.4 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.0 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.0 |
0.3 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 |
0.3 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
1.9 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
0.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.0 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.1 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.0 |
0.1 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.0 |
0.1 |
GO:0033488 |
cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.0 |
1.5 |
GO:0071431 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 |
0.0 |
GO:0045350 |
interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
| 0.0 |
0.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.0 |
0.1 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.0 |
0.6 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.0 |
0.1 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.0 |
0.4 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 |
0.2 |
GO:0009726 |
detection of endogenous stimulus(GO:0009726) |
| 0.0 |
0.6 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.0 |
0.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.5 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.0 |
0.1 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.0 |
0.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.0 |
GO:0035561 |
regulation of chromatin binding(GO:0035561) |
| 0.0 |
0.0 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.0 |
0.1 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.0 |
0.3 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.0 |
0.8 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.1 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.0 |
0.2 |
GO:0032069 |
regulation of nuclease activity(GO:0032069) |
| 0.0 |
0.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.0 |
0.0 |
GO:2000780 |
negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.0 |
0.1 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 |
2.5 |
GO:0071349 |
interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.0 |
0.4 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.0 |
0.7 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.4 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.0 |
0.7 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 |
0.2 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.6 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.0 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
1.0 |
GO:0036315 |
cellular response to sterol(GO:0036315) |
| 0.0 |
2.2 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.2 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
0.1 |
GO:0043368 |
positive T cell selection(GO:0043368) |
| 0.0 |
0.1 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.0 |
0.3 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.0 |
0.1 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.0 |
0.2 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.0 |
0.3 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.6 |
GO:0090128 |
regulation of synapse maturation(GO:0090128) |
| 0.0 |
0.7 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.0 |
0.1 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.0 |
0.3 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
| 0.0 |
0.2 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.0 |
0.3 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.0 |
0.3 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.0 |
0.2 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.0 |
1.3 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.9 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.0 |
0.1 |
GO:1902744 |
negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 0.0 |
0.4 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.0 |
0.2 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.0 |
0.0 |
GO:0043627 |
response to estrogen(GO:0043627) |
| 0.0 |
0.1 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
| 0.0 |
0.3 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.0 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
0.1 |
GO:0090263 |
positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 |
0.1 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.0 |
0.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.4 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.1 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.0 |
0.1 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.3 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.0 |
0.2 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.0 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.1 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 |
0.6 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.1 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.0 |
1.1 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.3 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.0 |
0.1 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.0 |
0.8 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.0 |
0.2 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.0 |
4.5 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.5 |
GO:0035914 |
skeletal muscle cell differentiation(GO:0035914) |
| 0.0 |
0.4 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.3 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
3.4 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.5 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 0.0 |
0.2 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.0 |
0.1 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.0 |
0.4 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
0.4 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.0 |
0.2 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.0 |
0.2 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.0 |
0.3 |
GO:0001836 |
release of cytochrome c from mitochondria(GO:0001836) |
| 0.0 |
0.2 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 |
0.1 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.0 |
0.7 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.0 |
0.8 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 |
0.1 |
GO:0002881 |
negative regulation of chronic inflammatory response(GO:0002677) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.0 |
0.1 |
GO:0032438 |
melanosome organization(GO:0032438) |
| 0.0 |
0.2 |
GO:1903597 |
negative regulation of gap junction assembly(GO:1903597) positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.0 |
0.2 |
GO:0046440 |
L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.0 |
0.9 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.3 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.3 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
0.0 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 |
0.1 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
0.1 |
GO:0010820 |
regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.0 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.2 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.4 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 |
0.2 |
GO:0061205 |
alveolar primary septum development(GO:0061143) paramesonephric duct development(GO:0061205) ductus arteriosus closure(GO:0097070) |
| 0.0 |
0.0 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 0.0 |
0.0 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.0 |
0.2 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 |
0.1 |
GO:0090092 |
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090092) |
| 0.0 |
0.2 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.0 |
0.3 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.0 |
0.1 |
GO:0035815 |
positive regulation of renal sodium excretion(GO:0035815) |
| 0.0 |
0.1 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 |
0.1 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) |
| 0.0 |
0.1 |
GO:0071774 |
response to fibroblast growth factor(GO:0071774) |
| 0.0 |
0.1 |
GO:0035087 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.0 |
16.9 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
| 0.0 |
0.8 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.1 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 |
0.1 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.0 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.3 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 |
0.1 |
GO:0001946 |
lymphangiogenesis(GO:0001946) |
| 0.0 |
0.3 |
GO:0042426 |
choline catabolic process(GO:0042426) |
| 0.0 |
0.2 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.0 |
0.9 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.0 |
0.1 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.0 |
0.2 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.0 |
0.5 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.7 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 |
0.1 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
1.7 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.1 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.0 |
0.1 |
GO:1904396 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of neuromuscular junction development(GO:1904396) |
| 0.0 |
0.1 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 0.0 |
0.0 |
GO:1903413 |
cellular response to bile acid(GO:1903413) |
| 0.0 |
0.3 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.5 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.0 |
0.3 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 |
0.3 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
0.2 |
GO:0021683 |
cerebellar granular layer morphogenesis(GO:0021683) |
| 0.0 |
0.1 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.3 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.0 |
0.3 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.0 |
0.1 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 |
0.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.3 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.0 |
0.2 |
GO:0009219 |
pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
| 0.0 |
0.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.0 |
0.1 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.0 |
0.2 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.0 |
0.5 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 |
0.4 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.3 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.0 |
0.1 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.0 |
0.3 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.0 |
0.2 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 |
0.5 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 |
1.0 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.0 |
GO:0032618 |
interleukin-15 production(GO:0032618) |
| 0.0 |
0.1 |
GO:0010952 |
positive regulation of peptidase activity(GO:0010952) |
| 0.0 |
0.1 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.0 |
0.1 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.0 |
0.1 |
GO:1901863 |
positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.0 |
0.1 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
| 0.0 |
0.2 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.3 |
GO:1901031 |
regulation of response to reactive oxygen species(GO:1901031) |
| 0.0 |
0.2 |
GO:0046125 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.0 |
0.6 |
GO:0010642 |
negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.0 |
0.1 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.0 |
0.1 |
GO:0045726 |
positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.0 |
0.1 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.1 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.0 |
0.1 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 |
0.4 |
GO:0009168 |
purine nucleoside monophosphate biosynthetic process(GO:0009127) purine ribonucleoside monophosphate biosynthetic process(GO:0009168) |
| 0.0 |
0.2 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.5 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.0 |
0.6 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.0 |
0.4 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.2 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.0 |
0.2 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.0 |
2.2 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.2 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 |
0.0 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.0 |
0.2 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 |
0.1 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.0 |
1.2 |
GO:0006364 |
rRNA processing(GO:0006364) |
| 0.0 |
0.3 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 |
0.6 |
GO:0048255 |
RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
| 0.0 |
1.0 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 |
0.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.2 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 |
0.1 |
GO:0060123 |
regulation of growth hormone secretion(GO:0060123) |
| 0.0 |
0.1 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.0 |
0.0 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.0 |
0.1 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.0 |
0.2 |
GO:0050869 |
negative regulation of B cell activation(GO:0050869) |
| 0.0 |
0.1 |
GO:1901077 |
regulation of relaxation of muscle(GO:1901077) regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.0 |
0.3 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.0 |
0.2 |
GO:0044819 |
mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
| 0.0 |
0.0 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.1 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.0 |
0.4 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.4 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.1 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.0 |
0.0 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.0 |
0.0 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.0 |
0.8 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 |
0.1 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
0.0 |
GO:0060926 |
sinoatrial node development(GO:0003163) cardiac pacemaker cell differentiation(GO:0060920) sinoatrial node cell differentiation(GO:0060921) cardiac pacemaker cell development(GO:0060926) |
| 0.0 |
0.1 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.0 |
0.1 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.0 |
0.0 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.0 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.0 |
0.2 |
GO:0044827 |
modulation by host of viral genome replication(GO:0044827) |
| 0.0 |
0.3 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 |
1.2 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.7 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.8 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.1 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.0 |
0.0 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.0 |
0.1 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 |
0.2 |
GO:0043970 |
histone H3-K9 acetylation(GO:0043970) |
| 0.0 |
0.0 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 |
0.5 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.0 |
0.8 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.2 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.0 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
| 0.0 |
0.2 |
GO:0045736 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.0 |
0.2 |
GO:0060828 |
regulation of canonical Wnt signaling pathway(GO:0060828) |
| 0.0 |
0.0 |
GO:0001545 |
primary ovarian follicle growth(GO:0001545) |
| 0.0 |
0.3 |
GO:1990182 |
exosomal secretion(GO:1990182) |
| 0.0 |
0.0 |
GO:0090158 |
endoplasmic reticulum membrane organization(GO:0090158) |
| 0.0 |
0.3 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 |
0.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.3 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.3 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.0 |
0.2 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.0 |
0.8 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.0 |
0.1 |
GO:0021912 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.0 |
0.4 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
0.3 |
GO:0070972 |
protein localization to endoplasmic reticulum(GO:0070972) |
| 0.0 |
0.2 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.1 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.0 |
0.5 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 |
0.5 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.0 |
0.0 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 |
1.1 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.1 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.0 |
1.0 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.3 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.0 |
0.4 |
GO:0000077 |
DNA damage checkpoint(GO:0000077) |
| 0.0 |
0.4 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.0 |
0.1 |
GO:0043584 |
nose development(GO:0043584) |
| 0.0 |
0.3 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.0 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.0 |
0.1 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.1 |
GO:0007632 |
visual behavior(GO:0007632) |
| 0.0 |
0.0 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.0 |
0.0 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.0 |
3.3 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
| 0.0 |
0.1 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.0 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 |
0.0 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 |
0.1 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
0.1 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 0.0 |
0.2 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.4 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
0.1 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.0 |
GO:0050927 |
positive regulation of positive chemotaxis(GO:0050927) |
| 0.0 |
0.3 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.0 |
0.2 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
0.2 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 |
0.1 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.0 |
1.1 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
0.1 |
GO:0051410 |
detoxification of nitrogen compound(GO:0051410) |
| 0.0 |
0.3 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.1 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.0 |
0.2 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.0 |
0.2 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.0 |
0.7 |
GO:0030837 |
negative regulation of actin filament polymerization(GO:0030837) |
| 0.0 |
0.1 |
GO:0002759 |
regulation of antimicrobial humoral response(GO:0002759) |
| 0.0 |
0.5 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.1 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.0 |
0.1 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
1.3 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.1 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.0 |
0.0 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.0 |
4.4 |
GO:0000398 |
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.0 |
0.1 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.0 |
0.1 |
GO:0048290 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.0 |
0.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 |
0.1 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.1 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.0 |
0.1 |
GO:0060021 |
palate development(GO:0060021) |
| 0.0 |
0.1 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.0 |
0.2 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 |
1.1 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.0 |
0.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.1 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.1 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 |
0.1 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.7 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.2 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.0 |
0.1 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.0 |
0.1 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.1 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.1 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.1 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.0 |
0.0 |
GO:0098780 |
response to mitochondrial depolarisation(GO:0098780) |
| 0.0 |
0.1 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.3 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.0 |
0.4 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.1 |
GO:0055098 |
response to low-density lipoprotein particle(GO:0055098) regulation of phagocytosis, engulfment(GO:0060099) |
| 0.0 |
0.1 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.0 |
0.1 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.0 |
0.7 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.1 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 |
0.7 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.0 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.1 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.0 |
0.3 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.1 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 |
0.2 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 |
0.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.3 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.0 |
0.0 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 |
0.0 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.0 |
0.0 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.0 |
0.1 |
GO:0071320 |
cellular response to cAMP(GO:0071320) |
| 0.0 |
0.1 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.0 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.0 |
0.0 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.0 |
0.1 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.0 |
0.0 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.0 |
0.1 |
GO:0007613 |
memory(GO:0007613) |
| 0.0 |
0.4 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.0 |
0.1 |
GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.0 |
0.0 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.0 |
0.2 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.6 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 |
0.1 |
GO:0010133 |
proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
| 0.0 |
0.2 |
GO:0046785 |
microtubule polymerization(GO:0046785) |
| 0.0 |
0.1 |
GO:0002418 |
immune response to tumor cell(GO:0002418) |
| 0.0 |
0.0 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.0 |
0.1 |
GO:0051412 |
response to corticosterone(GO:0051412) |
| 0.0 |
0.1 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.0 |
0.0 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.0 |
0.0 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.0 |
0.0 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 |
0.0 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.0 |
0.0 |
GO:0010044 |
response to aluminum ion(GO:0010044) |
| 0.0 |
0.1 |
GO:0051043 |
regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.0 |
0.0 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.0 |
0.0 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.6 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.1 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) glycosylceramide biosynthetic process(GO:0046476) |
| 0.0 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
0.0 |
GO:1901215 |
negative regulation of neuron death(GO:1901215) |
| 0.0 |
0.0 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.0 |
0.0 |
GO:0071174 |
mitotic spindle checkpoint(GO:0071174) |
| 0.0 |
0.0 |
GO:2000672 |
regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 |
0.0 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.1 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.0 |
0.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.0 |
0.0 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.0 |
0.0 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 |
0.0 |
GO:0060167 |
regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.0 |
0.1 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.0 |
0.0 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.1 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.0 |
0.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.0 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.0 |
0.0 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.0 |
0.1 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.0 |
0.0 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 |
0.3 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 |
0.8 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.0 |
0.1 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.2 |
GO:0044550 |
secondary metabolite biosynthetic process(GO:0044550) |
| 0.0 |
0.0 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.0 |
GO:0032930 |
positive regulation of superoxide anion generation(GO:0032930) |
| 0.0 |
0.1 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
